Thalassemia major is symbolized by severe anemia, and endurance depends on regular blood transfusion, with an inescapable iron overload resulting in multi organ loss due to free radical generation. Iron chelation is mandatory in this condition, but not sufficient to avoid iron deposition in tissues. For most symptomatic patients with thalassemia, there is no definite cure; only supportive management of the anemia is possible. This means it is passed down from one or both parents through their genes. People with Thalassemia are not able to make enough normal hemoglobin, which causes severe anemia. Patients with thalassemia intermediacy present later in life with moderate anemia and do not require regular transfusions. New pharmacological combinations are being tested, but none has yet made it into normal clinical practice for the analysis of beta-thalassemia major.
Commentary: International Journal of Public Health and Safety
Commentary: International Journal of Public Health and Safety
Editor Note: International Journal of Public Health and Safety
Editor Note: International Journal of Public Health and Safety
Review Article: International Journal of Public Health and Safety
Review Article: International Journal of Public Health and Safety
Review Article: International Journal of Public Health and Safety
Review Article: International Journal of Public Health and Safety
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Posters & Accepted Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care
Scientific Tracks Abstracts: Journal of Nursing & Care